Success Metrics

Active Trials
2(50%)

Phase Distribution

Ph phase_4
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
4(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Other(2)

Detailed Status

unknown2
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 44 (100.0%)

Trials by Status

recruiting125%
unknown250%
active_not_recruiting125%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruitingphase_4

Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)

NCT06854614
recruitingphase_4

Weight Loss Study: Genetics and Response to Naltrexone/Bupropion

NCT05919797
unknownphase_4

Use of Mysimba in Patients With Weight Regain After Bariatric Surgery

NCT04902625
unknownphase_4

Study of the Cardiometabolic Effects of Obesity Pharmacotherapy

NCT04575194

Clinical Trials (4)

Showing 4 of 4 trials
NCT06854614Phase 4

Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)

Active Not Recruiting
NCT05919797Phase 4

Weight Loss Study: Genetics and Response to Naltrexone/Bupropion

Recruiting
NCT04902625Phase 4

Use of Mysimba in Patients With Weight Regain After Bariatric Surgery

Unknown
NCT04575194Phase 4

Study of the Cardiometabolic Effects of Obesity Pharmacotherapy

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4